Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 501 of 1,261

  1. US 10280120

    Zirconia composition, zirconia pre-sintered body and zirconia sintered body, and dental product

    KURARAY NORITAKE DENTAL INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  2. US 10279042

    One-step processing of hydrogels for mechanically robust and chemically desired features

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted

  3. US 10279023

    Mucin-associated surface protein as a vaccine against chagas disease

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted

  4. US 10279015

    TPP-1 formulations and methods for treating CLN2 disease

    BIOMARIN PHARMACEUTICAL INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  5. US 10279029

    Immunogenic compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted

  6. US 10280422

    MiR-92 inhibitors and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  7. US 10278372

    Genetically modified cells, tissues, and organs for treating disease

    Regents of the University of Minnesota · Granted May 7, 2019 · Expires May 2, 2039

    granted

  8. US 10280158

    Immune adjustment compound, use thereof and pharmaceutical composition comprising same

    SuZhou Connect Biopharmaceuticals, Inc. · Granted May 7, 2019 · Expires May 2, 2039

    granted

  9. US 10278986

    Antibody-siRNA conjugates and uses therefor

    The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

    granted

  10. US 10280160

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted

  11. US 10279038

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted May 7, 2019 · Expires May 2, 2039

    granted

  12. US 10272099

    Tumor-selective combination therapy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  13. US 10273274

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  14. US 10273218

    BCL-3 inhibitors

    University College Cardiff Consultants Limited · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  15. US 10272146

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  16. US 10272069

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  17. US 10272139

    Process, tube and device for the preparation of wound healant composition

    RegenLab USA LLC · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  18. US 10272113

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  19. US 10273299

    Antibodies to tumor endothelial marker 8

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  20. US 10272074

    Inhibitors of glucocorticoid receptor translocation

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  21. US 10273482

    dsRNA for treating viral infection

    Arrowhead Pharmaceuticals, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  22. US 10273477

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  23. US 10273333

    Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  24. US 10273281

    CD80 extracellular domain polypeptides and their use in cancer treatment

    Five Prime Therapeutics, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.